前臂动静脉襻式移植物用于血液透析的单中心经验
单中心回顾性研究纳入2012至2019年98例前臂襻式人工血管动静脉移植物患者,75%获得初始通畅;同侧既往通路使初始通畅几率降低60%(OR 0.4,95%CI 0.1-0.9,P=0.03),同侧导管使移植物废弃风险升高(HR 2.6,95%CI 1.1-5.8,P=0.02);作者对长期透析患者使用前臂襻式人工血管的效用提出质疑。
要点
- 98例前臂襻式人工血管患者中75%获得初始通畅。
- 同侧既往通路使初始通畅几率降低60%(OR 0.4,95%CI 0.1-0.9,P=0.03)。
- 同侧导管使移植物废弃风险升高(HR 2.6,95%CI 1.1-5.8,P=0.02)。
核心结论
- 前臂襻式人工血管动静脉移植物在创建后一年内失败率高,作者对需要长期血液透析通路的患者使用此类移植物的效用提出质疑。
研究设计与样本
- 单机构回顾性病历审查,纳入2012至2019年期间创建肱动脉至肱静脉人工血管动静脉移植物的98例患者,平均年龄61.8(13.9)岁,42.9%为女性,采用逻辑回归和Cox比例风险模型评估。
主要发现
- 75%的患者获得初始通畅。
- 辅助初始通畅在6个月时为0.36(标准误0.07),在1年时为0.12(标准误0.05)。
- 功能通畅在6个月时为0.75(标准误0.07),在1年时为0.43(标准误0.09)。
- 术前血管直径与辅助初始通畅或功能通畅无关联。
- 同侧既往通路与初始通畅获得呈显著负相关,同侧既往通路患者获得初始通畅的几率降低60%(OR 0.4,95%CI 0.1-0.9,P=0.03);同侧导管与后续移植物废弃风险升高显著相关(HR 2.6,95%CI 1.1-5.8,P=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autogenous arteriovenous fistula (AVF) remains the standard of hemodialysis (HD) access; however, it cannot be reasonably obtained in all patients. For patients with contraindications to AVFs, prosthetic arteriovenous graft (AVG) remains an alternative. AVGs are plagued by high failure rates; however, there is a paucity of literature examining this. This study aims to examine a single-center review of outcomes of forearm loop AVGs in patients requiring HD access. METHODS: A single institution, retrospective chart review was completed from 2012 to 2019, including demographics, end-stage renal disease etiology, brachial vessel diameters, and comorbidities. Logistic regression and Cox proportional hazard models were evaluated. Outcomes were defined as primary patency (time elapsed from graft creation until it was utilized as the patient's primary access), primary-assisted patency (time from primary access to intervention to maintain patency), and functional patency (time from graft placement until graft failure). Additionally, multinomial regression models were used to evaluate associations with categorical number of required interventions. RESULTS: Ninety-eight patients [mean age 61.8 (13.9) years, 42.9% female] were identified as having brachial artery to brachial vein AVG creation during the study period, of which 75% achieved primary patency. Primary-assisted patency was 0.36 [standard error (SE) 0.07] at 6 months and 0.12 (SE 0.05) at 1 year. Functional patency was 0.75 (SE 0.07) at 6 months and 0.43 (SE 0.09) at 1 year. No association between preoperative vessel diameters and primary-assisted or functional patency was observed. Interestingly, there was a significant negative association between previous ipsilateral access and achievement of primary patency with a 60% decrease in odds of achieving primary patency in patients with previous ipsilateral access [odds ratio 0.4, 95% confidence interval (CI) 0.1-0.9, P = 0.03]. There was also noted to be a significant association between the presence of an ipsilateral catheter and increased risk of subsequent abandonment of the AVG (hazard ratio 2.6, 95% CI 1.1-5.8, P = 0.02). CONCLUSIONS: Prosthetic forearm loop AVGs remain hindered in their utility as they show high rates of graft failure within a year of creation. A significant patient-specific factor leading to this was not clearly demonstrated. As guidelines change regarding the nature of dialysis access for patients on HD, these results draw into question the utility of prosthetic forearm loop grafts in patients requiring long-term HD access.
引用
- Brastauskas IM, Patel N, German Z, et al. A Single-Center Experience with Forearm Arteriovenous Loop Grafts for Hemodialysis. Ann Vasc Surg. 2022. PMID: 35817384. doi:10.1016/j.avsg.2022.06.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。